Hyperfine, Inc. — Director's Dealing 2022

Dec 20, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hyperfine, Inc. (HYPR)
CIK: 0001833769
Period of Report: 2021-12-29

Reporting Person: HC Sponsor LLC (10% Owner)
Reporting Person: HealthCor Group, LLC (10% Owner)
Reporting Person: Cohen Arthur Bruce (10% Owner)
Reporting Person: Healey Joseph Patrick (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-29	Class A Common Stock	P	100000	$7.000	Acquired	1100000	Indirect
2022-01-10	Class A Common Stock	P	13677	$6.698	Acquired	1113677	Indirect
2022-01-11	Class A Common Stock	P	2913	$6.728	Acquired	1116590	Indirect
2022-01-12	Class A Common Stock	P	8410	$6.569	Acquired	1125000	Indirect
2022-01-21	Class A Common Stock	P	25000	$4.502	Acquired	1150000	Indirect
2022-01-26	Class A Common Stock	P	78053	$3.747	Acquired	1228053	Indirect
2022-02-03	Class A Common Stock	P	21947	$4.000	Acquired	1250000	Indirect
2022-12-16	Class A Common Stock	J	5534000	—	Disposed	0	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	5534000	Direct

Footnotes

F1: This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein.

F2: Includes 1,000,000 shares previously reported as owned directly. These shares are held by affiliates of the Reporting Persons. HealthCor Group shares voting and/or dispositive control over these securities.

F3: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.676 to $6.75, inclusive. The reporting persons undertake to provide to the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (6) to this Form 4.

F4: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.724 to $6.75, inclusive.

F5: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.55 to $6.613, inclusive.

F6: The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.731 to $3.75, inclusive.

F7: Sponsor distributed these shares to its members on a pro rata basis for no consideration.

F8: A fund controlled by HealthCor Group and Messrs. Cohen and Healey are each members of Sponsor and received 526,020, 781,226 and 781, 227 shares in the distribution. Those shares are now owned by such persons directly.